Researcher
Jaak JANSSENS
- Keywords:Medicine
- Disciplines:Other clinical sciences not elsewhere classified
Affiliations
- Healthcare & ethics (Department)
Member
From1 Jan 2020 → 30 Sep 2022 - Healthcare & ethics (Research group)
Member
From1 Jan 2020 → 30 Sep 2022 - Biomedical Research Institute (Research institute)
Member
From15 Nov 2006 → 30 Sep 2022 - Faculty of Medicine and Life Sciences (Faculty)
Member
From15 Nov 2006 → 30 Sep 2022 - Physiology - Biochemistry - Immunology (Department)
Member
From15 Nov 2006 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From15 Nov 2006 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Sep 1998 → 31 Dec 2019
Publications
1 - 10 of 12
- Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers(2023)
Authors: Yanrong Su, Nhi M. M. Dang, Herman Depypere, Julia Santucci-Pereira, Pedro J. J. Gutierrez-Diez, Joice Kanefsky, Jaak JANSSENS, Jose Russo
Pages: 126 - 138 - New leadership for the European Cancer Prevention Organization(2023)
Authors: Jaak JANSSENS
Pages: 99 - 102 - Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers(2021)
Authors: Herman Depypere, Yanrong Su, Nhi Dang, Frank Stanczyk, Jaak JANSSENS, Jose Russo, Bruce Poppe
Pages: 195 - 203 - SCREENING FOR IMMUNOGLOBULIN A ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS(2020)
Authors: Patrick VANDORMAEL, Dana QUADEN, Pieter RUYTINX, Jaak JANSSENS, Johan VANHOOF, Piet GEUSENS, Veerle SOMERS
Pages: 1916 - 1916 - Treatment choices based on multiplatform profiling platform, unlike those with sequencing alone, do not cause a cost explosion in refractory cancer patients(2017)
Authors: K. J. Russell, Jaak JANSSENS, A. Dean, A. Hernandez, A. Voss
Pages: A579 - A579 - COMPARISON OF UTILITY COST IN THREE COMMERCIALLY AVAILABLE PRECISION MEDICINE APPROACHES IN ONCOLOGY(2017)
Authors: K. J. Russell, Jaak JANSSENS, A. Dean, A. Hernandez, A. Voss
Pages: A590 - A590 - Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix(2012)
Authors: F. A. Machado, Jaak JANSSENS, M. A. Michelin, E. F. C. Murta
Pages: 27 - 31 - IMPACT OF MAMMAPRINT ON THE ROUTINE TREATMENT DECISION MAKING PROCESS IN AN UNSELECTED EARLY BREAST CANCER PATIENT POPULATION IN BELGIUM(2010)
Authors: P. G. Cusumano, F. Liebens, B. Carly, G. Jerusalem, E. Lifrange, Jaak JANSSENS, J. VLASSELAER, V. Jossa
Pages: 86 - 87 - A RETROSPECTIVE SURVEY OF SYSTEMIC ANTICANCER THERAPY IN WOMEN WITH METASTATIC BREAST CANCER (MBC) IN BELGIUM(2010)
Authors: C. Fontaine, Jaak JANSSENS, C. Dopchie, C. Nouwynck
Pages: 108 - 108 - Efficacy and safety of direct and frontal macrobiopsies in breast cancer(2009)
Authors: Ann Cornelis, Marcel Verjans, Thierry Van den Bosch, Katrien Wouters, Johan Van Robaeys, Jaak JANSSENS
Pages: 280 - 284